Evidence map›Paper›PMID 32509202›Full record

ArticleAmerican journal of translational research2020

Magnetic resonance imaging semantic and quantitative features analyses: an additional diagnostic tool for breast phyllodes tumors.

Wenjuan Ma, Xinpeng Guo, Liangsheng Liu, Lisha Qi, Peifang Liu, Ying Zhu, Xiqi Jian, Guijun Xu, Xin Wang, Hong Lu and 1 more

Abstract read
In one paragraph

Article in American journal of translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenjuan MaDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Huanhuxi Road, Hexi District, Tianjin 300060, P. R. China.
Xinpeng GuoDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Huanhuxi Road, Hexi District, Tianjin 300060, P. R. China.
Liangsheng LiuDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Huanhuxi Road, Hexi District, Tianjin 300060, P. R. China.
Lisha QiDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Huanhuxi Road, Hexi District, Tianjin 300060, P. R. China.
Peifang LiuDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Huanhuxi Road, Hexi District, Tianjin 300060, P. R. China.
Ying ZhuDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Huanhuxi Road, Hexi District, Tianjin 300060, P. R. China.
Xiqi JianDepartment of Biomedical and Engineering, Tianjin Medical University 22 Qixiangtai Road, Heping District, Tianjin 300070, P. R. China.
Guijun XuDepartment of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin, P. R. China.
Xin WangDepartment of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University 30 Gaotanyan Street Shapingba District, Chongqing 400038, P. R. China.
Hong LuDepartment of Breast Imaging, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Huanhuxi Road, Hexi District, Tianjin 300060, P. R. China.
Chao ZhangDepartment of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer Tianjin, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to differentiate benign and non-benign (borderline/malignant) phyllodes tumors of the breast by the semantic and quantitative features in magnetic resonance imaging (MRI).

methodsThe female patients, diagnosed with phyllodes tumors by MRI and pathological test, were retrospectively selected from December, 2006 to April, 2019. The MRI of benign, borderline and malignant phyllodes tumors was analyzed using 8 semantic features and 20 computed quantitative features from diffuse contrast-enhanced magnetic resonance imaging (DCE-MRI). The semantic features were analyzed by univariate analysis. The least absolute shrinkage and selection operator (LASSO) method was used to identify the optimal subset of MRI quantitative features. According to the results from multivariate logistic regression for the semantic and quantitative features, the model was constructed to differentiate benign and non-benign (borderline/malignant) phyllodes tumors.

resultsThirty-two benign (58.18%), 13 borderline (23.64%) and 10 malignant (18.18%) phyllodes tumors were identified in 54 patients. Five semantic features were proved to be significantly correlated with pathologic grade, including size, the T1 weighted image signal intensity, fat-saturated T2-weighted image signal intensity, enhanced signal intensity, and kinetic curve pattern. With the analysis of LASSO method, three quantitative texture features with significant predictive ability were selected. The model combining both the semantic and quantitative features was proved to have good performance in differentiation on phyllodes tumors, yielding an area under receiver operating characteristic curve, accuracy, sensitivity and specificity of 0.893, 0.933, 1.000, and 0.818, respectively.

conclusionThe constructed model based on the semantic and quantitative features of DCE-MRI can significantly improve the differential diagnosis of phyllodes tumors in breast.

Indexed as

breastMRIPhyllodes tumorquantitativesemantic

Identifiers

PMID32509202
PMCPMC7270016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.